Equities analysts predict that Marchex, Inc. (NASDAQ:MCHX) will post $0.01 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Marchex’s earnings. The lowest EPS estimate is $0.00 and the highest is $0.01. Marchex also posted earnings per share of $0.01 in the same quarter last year. The firm is expected to issue its next quarterly earnings results on Thursday, February 21st.
On average, analysts expect that Marchex will report full-year earnings of ($0.01) per share for the current year. For the next year, analysts forecast that the business will report earnings of $0.02 per share, with EPS estimates ranging from $0.01 to $0.02. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research firms that cover Marchex.
Marchex (NASDAQ:MCHX) last issued its quarterly earnings data on Monday, November 5th. The technology company reported ($0.02) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.02). Marchex had a negative net margin of 3.01% and a negative return on equity of 3.65%. The firm had revenue of $20.01 million during the quarter, compared to the consensus estimate of $19.71 million.
Shares of MCHX stock traded up $0.07 during mid-day trading on Friday, reaching $3.40. 402,300 shares of the company’s stock traded hands, compared to its average volume of 176,975. Marchex has a 12 month low of $2.47 and a 12 month high of $3.67. The company has a market cap of $131.82 million, a price-to-earnings ratio of -24.29 and a beta of 1.07.
In other news, major shareholder Edenbrook Capital, Llc bought 44,831 shares of the company’s stock in a transaction that occurred on Wednesday, October 17th. The stock was bought at an average price of $2.55 per share, with a total value of $114,319.05. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders purchased a total of 497,090 shares of company stock valued at $1,436,497 in the last ninety days. 22.49% of the stock is currently owned by insiders.
A number of institutional investors have recently modified their holdings of MCHX. BlackRock Inc. raised its stake in Marchex by 3.6% during the 2nd quarter. BlackRock Inc. now owns 794,348 shares of the technology company’s stock worth $2,430,000 after buying an additional 27,930 shares during the period. Dimensional Fund Advisors LP raised its stake in Marchex by 8.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,769,937 shares of the technology company’s stock worth $5,416,000 after buying an additional 131,797 shares during the period. Renaissance Technologies LLC raised its stake in Marchex by 2.3% during the 2nd quarter. Renaissance Technologies LLC now owns 1,737,734 shares of the technology company’s stock worth $5,317,000 after buying an additional 38,334 shares during the period. Ancora Advisors LLC raised its stake in shares of Marchex by 33.5% in the third quarter. Ancora Advisors LLC now owns 1,517,570 shares of the technology company’s stock worth $4,219,000 after purchasing an additional 381,194 shares during the last quarter. Finally, Cpwm LLC raised its stake in shares of Marchex by 15.0% in the third quarter. Cpwm LLC now owns 260,860 shares of the technology company’s stock worth $725,000 after purchasing an additional 34,013 shares during the last quarter. 49.55% of the stock is owned by institutional investors.
Marchex, Inc is a call analytics company, which engages in connecting online behavior to real-world and offline actions. The company offers driving phone calls and local leads platform through the Call-Driven segment. Its products include call, search, and display and video analytics. The company was founded by Russell C.
Featured Article: Fundamental Analysis and Individual Investors
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.